1 | 1 | | By: Ellis S.B. No. 1886 |
---|
2 | 2 | | |
---|
3 | 3 | | |
---|
4 | 4 | | A BILL TO BE ENTITLED |
---|
5 | 5 | | AN ACT |
---|
6 | 6 | | relating to diagnostic testing of pregnant women and certain |
---|
7 | 7 | | newborns. |
---|
8 | 8 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
---|
9 | 9 | | SECTION 1. The heading to Section 81.090, Health and Safety |
---|
10 | 10 | | Code, is amended to read as follows: |
---|
11 | 11 | | Sec. 81.090. DIAGNOSTIC [SEROLOGIC] TESTING DURING |
---|
12 | 12 | | PREGNANCY AND AFTER BIRTH. |
---|
13 | 13 | | SECTION 2. Section 81.090, Health and Safety Code, is |
---|
14 | 14 | | amended by amending Subsections (a), (b), (c), (i), (j), (k), and |
---|
15 | 15 | | (l) and adding Subsections (a-1), (c-1), and (c-2) to read as |
---|
16 | 16 | | follows: |
---|
17 | 17 | | (a) A physician or other person permitted by law to attend a |
---|
18 | 18 | | pregnant woman during gestation or at delivery of an infant shall: |
---|
19 | 19 | | (1) take or cause to be taken a sample of the woman's |
---|
20 | 20 | | blood or other appropriate specimen at the first examination and |
---|
21 | 21 | | visit; |
---|
22 | 22 | | (2) submit the sample to an appropriately certified |
---|
23 | 23 | | [a] laboratory [approved under this section] for diagnostic testing |
---|
24 | 24 | | approved by the United States Food and Drug Administration for: |
---|
25 | 25 | | (A) [a standard serologic test for] syphilis |
---|
26 | 26 | | [approved by the board]; |
---|
27 | 27 | | (B) [a standard serologic test for] HIV infection |
---|
28 | 28 | | [approved by the board]; and |
---|
29 | 29 | | (C) [a standard serologic test for] hepatitis B |
---|
30 | 30 | | infection [approved by the board]; and |
---|
31 | 31 | | (3) retain a report of each case for nine months and |
---|
32 | 32 | | deliver the report to any successor in the case. |
---|
33 | 33 | | (a-1) A physician or other person permitted by law to attend |
---|
34 | 34 | | a pregnant woman during gestation or at delivery of an infant shall: |
---|
35 | 35 | | (1) take or cause to be taken a sample of the woman's |
---|
36 | 36 | | blood or other appropriate specimen at an examination in the third |
---|
37 | 37 | | trimester of the pregnancy; |
---|
38 | 38 | | (2) submit the sample to an appropriately certified |
---|
39 | 39 | | laboratory for a diagnostic test approved by the United States Food |
---|
40 | 40 | | and Drug Administration for HIV infection; and |
---|
41 | 41 | | (3) retain a report of each case for nine months and |
---|
42 | 42 | | deliver the report to any successor in the case. |
---|
43 | 43 | | (b) A successor is presumed to have complied with this |
---|
44 | 44 | | section if the successor in good faith obtains a record that |
---|
45 | 45 | | indicates compliance with Subsections (a) and (a-1), if applicable. |
---|
46 | 46 | | (c) A physician or other person in attendance at a delivery |
---|
47 | 47 | | shall: |
---|
48 | 48 | | (1) take or cause to be taken a sample of blood or |
---|
49 | 49 | | other appropriate specimen from the mother on admission for |
---|
50 | 50 | | delivery; and |
---|
51 | 51 | | (2) submit the sample to an appropriately certified |
---|
52 | 52 | | [a] laboratory [approved under this section] for diagnostic testing |
---|
53 | 53 | | approved by the United States Food and Drug Administration for: |
---|
54 | 54 | | (A) [a standard serologic test for] syphilis |
---|
55 | 55 | | [approved by the board]; and |
---|
56 | 56 | | (B) [a standard serologic test for HIV infection |
---|
57 | 57 | | approved by the board; and |
---|
58 | 58 | | [(C) a standard serologic test for] hepatitis B |
---|
59 | 59 | | infection [approved by the board]. |
---|
60 | 60 | | (c-1) If the physician or other person in attendance at the |
---|
61 | 61 | | delivery does not find in the woman's medical records results from |
---|
62 | 62 | | the diagnostic test for HIV infection performed under Subsection |
---|
63 | 63 | | (a-1), the physician or person shall: |
---|
64 | 64 | | (1) take or cause to be taken a sample of blood or |
---|
65 | 65 | | other appropriate specimen from the mother; |
---|
66 | 66 | | (2) submit the sample to an appropriately certified |
---|
67 | 67 | | laboratory for diagnostic testing approved by the United States |
---|
68 | 68 | | Food and Drug Administration for HIV infection; and |
---|
69 | 69 | | (3) instruct the laboratory to expedite the processing |
---|
70 | 70 | | of the test so that the results are received less than six hours |
---|
71 | 71 | | after the time the sample is submitted. |
---|
72 | 72 | | (c-2) If the physician or other person in attendance at the |
---|
73 | 73 | | delivery does not find in the woman's medical records results from a |
---|
74 | 74 | | diagnostic test for HIV infection performed under Subsection (a-1), |
---|
75 | 75 | | and the diagnostic test for HIV infection was not performed before |
---|
76 | 76 | | delivery under Subsection (c-1), the physician or other person in |
---|
77 | 77 | | attendance at delivery shall: |
---|
78 | 78 | | (1) take or cause to be taken a sample of blood or |
---|
79 | 79 | | other appropriate specimen from the newborn child less than two |
---|
80 | 80 | | hours after the time of birth; |
---|
81 | 81 | | (2) submit the sample to an appropriately certified |
---|
82 | 82 | | laboratory for a diagnostic test approved by the United States Food |
---|
83 | 83 | | and Drug Administration for HIV infection; and |
---|
84 | 84 | | (3) instruct the laboratory to expedite the processing |
---|
85 | 85 | | of the test so that the results are received less than six hours |
---|
86 | 86 | | after the time the sample is submitted. |
---|
87 | 87 | | (i) Before conducting or causing to be conducted a |
---|
88 | 88 | | diagnostic [standard serologic] test for HIV infection under this |
---|
89 | 89 | | section, the physician or other person shall advise the woman that |
---|
90 | 90 | | the result of a test taken under this section is confidential as |
---|
91 | 91 | | provided by Subchapter F, but that the test is not anonymous. The |
---|
92 | 92 | | physician or other person shall explain the difference between a |
---|
93 | 93 | | confidential and an anonymous test to the woman and that an |
---|
94 | 94 | | anonymous test may be available from another entity. The physician |
---|
95 | 95 | | or other person shall make the information available in another |
---|
96 | 96 | | language, if needed, and if resources permit. The information |
---|
97 | 97 | | shall be provided by the physician or another person, as needed, in |
---|
98 | 98 | | a manner and in terms understandable to a person who may be |
---|
99 | 99 | | illiterate if resources permit. |
---|
100 | 100 | | (j) The result of a [standard] test for HIV infection under |
---|
101 | 101 | | Subsection (a)(2)(B), (a-1), (c-1), or (c-2) [(c)(2)(B)] is a test |
---|
102 | 102 | | result for purposes of Subchapter F. |
---|
103 | 103 | | (k) Before the [blood] sample is taken, the health care |
---|
104 | 104 | | provider shall distribute to the patient printed materials about |
---|
105 | 105 | | AIDS, HIV, hepatitis B, and syphilis. A health care provider shall |
---|
106 | 106 | | verbally notify the patient that an HIV test shall be performed if |
---|
107 | 107 | | the patient does not object. If the patient objects, the patient |
---|
108 | 108 | | shall be referred to an anonymous testing facility or instructed |
---|
109 | 109 | | about anonymous testing methods. The health care provider shall |
---|
110 | 110 | | note on the medical records that the distribution of printed |
---|
111 | 111 | | materials was made and that verbal notification was given. The |
---|
112 | 112 | | materials shall be provided to the health care provider by the |
---|
113 | 113 | | department [Texas Department of Health] and shall be prepared and |
---|
114 | 114 | | designed to inform the patients about: |
---|
115 | 115 | | (1) the incidence and mode of transmission of AIDS, |
---|
116 | 116 | | HIV, hepatitis B, and syphilis; |
---|
117 | 117 | | (2) how being infected with HIV, AIDS, hepatitis B, or |
---|
118 | 118 | | syphilis could affect the health of their child; |
---|
119 | 119 | | (3) the available cure for syphilis; |
---|
120 | 120 | | (4) the available treatment to prevent |
---|
121 | 121 | | maternal-infant HIV transmission; and |
---|
122 | 122 | | (5) methods to prevent the transmission of the HIV |
---|
123 | 123 | | virus, hepatitis B, and syphilis. |
---|
124 | 124 | | (l) A physician or other person may not conduct a diagnostic |
---|
125 | 125 | | [standard] test for HIV infection under Subsection (a)(2)(B), |
---|
126 | 126 | | (a-1), or (c-1) [(c)(2)(B)] if the woman objects. A physician or |
---|
127 | 127 | | other person may not conduct a diagnostic test for HIV infection |
---|
128 | 128 | | under Subsection (c-2) if a parent, managing conservator, or |
---|
129 | 129 | | guardian objects. |
---|
130 | 130 | | SECTION 3. Subsections (d), (e), (f), and (h), Section |
---|
131 | 131 | | 81.090, Health and Safety Code, are repealed. |
---|
132 | 132 | | SECTION 4. (a) Subsections (a), (c), (i), and (k), Section |
---|
133 | 133 | | 81.090, Health and Safety Code, as amended by this Act, apply only |
---|
134 | 134 | | to a test performed on or after the effective date of this Act. A |
---|
135 | 135 | | test performed before the effective date of this Act is covered by |
---|
136 | 136 | | the law in effect immediately before the effective date of this Act, |
---|
137 | 137 | | and the former law is continued in effect for that purpose. |
---|
138 | 138 | | (b) Subsections (a-1), (c-1), and (c-2), Section 81.090, |
---|
139 | 139 | | Health and Safety Code, as added by this Act, and Subsections (b), |
---|
140 | 140 | | (j), and (l), Section 81.090, Health and Safety Code, as amended by |
---|
141 | 141 | | this Act, apply only to a physician or other person attending a |
---|
142 | 142 | | pregnant woman during gestation or at delivery of an infant on or |
---|
143 | 143 | | after January 1, 2010. |
---|
144 | 144 | | SECTION 5. This Act takes effect September 1, 2009. |
---|